Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiomyopathy and abnormal mitochondrial function

J Marin-Garcia1, M J Goldenthal

  • 1Pediatric Cardiology Group of New Jersey, Highland Park, NJ 08904.

Cardiovascular Research
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial DNA defects in cardiomyopathy.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Isolation and characterization of a maltose transport mutant in the yeast Saccharomyces cerevisiae.

Current genetics·2013
Same author

Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure.

Cardiovascular research·2001
Same author

The complete sequence of mtDNA genes in idiopathic dilated cardiomyopathy shows novel missense and tRNA mutations.

Journal of cardiac failure·2001
Same author

Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children.

Journal of inherited metabolic disease·2000
Same author

Heart mitochondrial DNA and enzyme changes during early human development.

Molecular and cellular biochemistry·2000
Same journal

Metabolic crisis and TRPM4 activation cause QT prolongation in TANGO2 deficiency disorder.

Cardiovascular research·2026
Same journal

Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.

Cardiovascular research·2026
Same journal

Endothelial-to-mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models and therapies.

Cardiovascular research·2026
Same journal

The gut-heart axis in cardio-oncology.

Cardiovascular research·2026
Same journal

Proteomic signatures as biomarkers of atherosclerosis burden.

Cardiovascular research·2026
Same journal

Immunomodulatory endothelial cells contribute to T cell recruitment and activation via antigen presentation on MHC II.

Cardiovascular research·2026
See all related articles

Cardiomyopathy diagnosis relies on clinical data, but mitochondrial defects are understudied. Research into mitochondrial biochemistry offers new therapeutic avenues for these heart muscle diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Cardiomyopathy diagnosis primarily uses clinical and morphological assessments.
  • Known etiological factors include metabolic, viral, chemical, genetic, and immunological influences.
  • The role of mitochondrial dysfunction in cardiomyopathy remains poorly understood.

Purpose of the Study:

  • To investigate the role of the respiratory chain and biochemical mitochondrial defects in cardiomyopathy.
  • To enhance understanding of cardiomyopathy pathogenesis.
  • To identify potential targets for specific therapeutic interventions.

Main Methods:

  • Review of existing literature on cardiomyopathy etiology and mitochondrial function.
  • Analysis of biochemical and molecular data related to mitochondrial defects.

Related Experiment Videos

  • Correlation of mitochondrial abnormalities with clinical and morphological cardiomyopathy criteria.

    • Main Results:

    • Mitochondrial defects, particularly in the respiratory chain, are implicated in cardiomyopathy.
    • Biochemical abnormalities within mitochondria contribute to disease development.
    • Understanding these defects is crucial for disease mechanisms.

    Conclusions:

    • Mitochondrial biochemistry and molecular biology are critical areas for cardiomyopathy research.
    • Further investigation into mitochondrial defects may reveal novel diagnostic markers.
    • Targeting mitochondrial pathways presents a promising strategy for cardiomyopathy therapy.